The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.1 - Manufacture of basic pharmaceutical products
600 jobs Number of planned job losses
Announcement Date
14 June 2012
Employment effect (start)
31 July 2012
Foreseen end date
31 December 2013
Description
The pharmaceutical company Lundbeck announced plans to restructure its commercial organisation, which involves the reduction of around 600 positions. The jobs will be mainly cut in Europe.
The reorganisation aims to mitigate increased pressure from healthcare reforms, generic competition and uncertainty regarding pricing and reimbursement in Europe. The company has informed its European Works Council about the restructuring plans.
Eurofound (2012), Lundbeck, Internal restructuring in World, factsheet number 73819, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/73819.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
